14,15-dihetre

14,15-dihetre is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 204 references associated with 14,15-dihetre in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 14,15-dihetre

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 14,15-dihetre

MeSH term MeSH ID Detail
Hypertrophy, Right Ventricular D017380 4 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypertension D006973 115 associated lipids
Total 4

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 14,15-dihetre

Download all related citations
Per page 10 20 50 | Total 46
Authors Title Published Journal PubMed Link
Schebb NH et al. Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors. 2011 Anal Bioanal Chem pmid:21479549
Nithipatikom K et al. Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay. 1997 Anal. Biochem. pmid:9073364
Oleksiak MF et al. Identification and regulation of a new vertebrate cytochrome P450 subfamily, the CYP2Ps, and functional characterization of CYP2P3, a conserved arachidonic acid epoxygenase/19-hydroxylase. 2003 Arch. Biochem. Biophys. pmid:12623071
Krötz F et al. Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:14715644
Theken KN et al. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. 2012 Atherosclerosis pmid:22503544
Ghosh S et al. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. 2008 Basic Clin. Pharmacol. Toxicol. pmid:18312493
Liu JY et al. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. 2010 Biochem. Pharmacol. pmid:19896470
Widstrom RL et al. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase. 2003 Biochemistry pmid:14529287
Shen HC et al. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19682899
Roy U et al. Cytochrome P450/NADPH-dependent formation of trans epoxides from trans-arachidonic acids. 2004 Bioorg. Med. Chem. Lett. pmid:15013014